These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 30097840)

  • 1. Long-term Growth in Congenital Adrenal Hyperplasia.
    Maheshwari A; Khadilkar V; Gangodkar P; Khadilkar A
    Indian J Pediatr; 2019 Feb; 86(2):154-158. PubMed ID: 30097840
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HYDROCORTISONE THERAPY AND GROWTH TRAJECTORY IN CHILDREN WITH CLASSICAL CONGENITAL ADRENAL HYPERPLASIA.
    Bizzarri C; Improda N; Maggioli C; Capalbo D; Roma S; Porzio O; Salerno M; Cappa M
    Endocr Pract; 2017 May; 23(5):546-556. PubMed ID: 28225306
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reduced final height outcome in congenital adrenal hyperplasia under prednisone treatment: deceleration of growth velocity during puberty.
    Bonfig W; Bechtold S; Schmidt H; Knorr D; Schwarz HP
    J Clin Endocrinol Metab; 2007 May; 92(5):1635-9. PubMed ID: 17299071
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term follow-up of children with classic congenital adrenal hyperplasia: suggestions for age dependent treatment in childhood and puberty.
    Pijnenburg-Kleizen KJ; Thomas CMG; Otten BJ; Roeleveld N; Claahsen-van der Grinten HL
    J Pediatr Endocrinol Metab; 2019 Oct; 32(10):1055-1063. PubMed ID: 31573958
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Experience with long-term glucocorticoid treatment in congenital adrenal hyperplasia: growth pattern compared with genetic height potential.
    Aycan Z; Ocal G; Berberoglu M; Cetinkaya E; Adiyaman P; Evliyaoglu O
    J Pediatr Endocrinol Metab; 2006 Mar; 19(3):245-51. PubMed ID: 16607925
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The relation of peripubertal and pubertal growth to final adult height in children with classic congenital adrenal hyperplasia.
    Bomberg EM; Addo OY; Kyllo J; Gonzalez-Bolanos MT; Ltief AM; Pittock S; Himes JH; Miller BS; Sarafoglou K
    J Pediatr; 2015 Mar; 166(3):743-50. PubMed ID: 25557963
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early growth, pubertal development, body mass index and final height of patients with congenital adrenal hyperplasia: factors influencing the outcome.
    Manoli I; Kanaka-Gantenbein Ch; Voutetakis A; Maniati-Christidi M; Dacou-Voutetakis C
    Clin Endocrinol (Oxf); 2002 Nov; 57(5):669-76. PubMed ID: 12390343
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Growth patterns in the first three years of life in children with classical congenital adrenal hyperplasia diagnosed by newborn screening and treated with low doses of hydrocortisone.
    Bonfig W; Schmidt H; Schwarz HP
    Horm Res Paediatr; 2011; 75(1):32-7. PubMed ID: 20714115
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Final height and body disproportion in thalassaemic boys and girls with spontaneous or induced puberty.
    Filosa A; Di Maio S; Baron I; Esposito G; Galati MG
    Acta Paediatr; 2000 Nov; 89(11):1295-301. PubMed ID: 11106039
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Growth pattern of untreated boys with simple virilizing congenital adrenal hyperplasia indicates relative androgen insensitivity during the first six months of life.
    Bonfig W; Schwarz HP
    Horm Res Paediatr; 2011; 75(4):264-8. PubMed ID: 21196707
    [TBL] [Abstract][Full Text] [Related]  

  • 11. True precocious puberty complicating congenital adrenal hyperplasia: treatment with a luteinizing hormone-releasing hormone analog.
    Pescovitz OH; Comite F; Cassorla F; Dwyer AJ; Poth MA; Sperling MA; Hench K; McNemar A; Skerda M; Loriaux DL
    J Clin Endocrinol Metab; 1984 May; 58(5):857-61. PubMed ID: 6368580
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment and disease effects on short-term growth and adult height in children and adolescents with 21-hydroxylase deficiency.
    Hauffa BP; Winter A; Stolecke H
    Klin Padiatr; 1997; 209(2):71-7. PubMed ID: 9113619
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The urinary steroidome of treated children with classic 21-hydroxylase deficiency.
    Kamrath C; Wettstaedt L; Boettcher C; Hartmann MF; Wudy SA
    J Steroid Biochem Mol Biol; 2017 Jan; 165(Pt B):396-406. PubMed ID: 27544322
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Growth curves for congenital adrenal hyperplasia from a national retrospective cohort.
    Bretones P; Riche B; Pichot E; David M; Roy P; Tardy V; Kassai B; Gaillard S; Bernoux D; Morel Y; Chatelain P; Nicolino M; Cornu C;
    J Pediatr Endocrinol Metab; 2016 Dec; 29(12):1379-1388. PubMed ID: 27852974
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Growth patterns and final height in congenital adrenal hyperplasia due to classical 21-hydroxylase deficiency. Results of a multicenter study.
    Hargitai G; Sólyom J; Battelino T; Lebl J; Pribilincová Z; Hauspie R; Kovács J; Waldhauser F; Frisch H;
    Horm Res; 2001; 55(4):161-71. PubMed ID: 11598369
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Non-classical 21-hydroxylase deficiency in infancy and childhood: the effect of time of initiation of therapy on puberty and final height.
    Weintrob N; Dickerman Z; Sprecher E; Galatzer A; Pertzelan A
    Eur J Endocrinol; 1997 Feb; 136(2):188-95. PubMed ID: 9116914
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Growth and adult height in patients with congenital adrenal hyperplasia].
    Kolousková S; Zemková D; Snajderová M; Lebl J
    Cas Lek Cesk; 1995 Nov; 134(21):689-91. PubMed ID: 8556761
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Longitudinal analysis of growth and puberty in 21-hydroxylase deficiency patients.
    Van der Kamp HJ; Otten BJ; Buitenweg N; De Muinck Keizer-Schrama SM; Oostdijk W; Jansen M; Delemarre-de Waal HA; Vulsma T; Wit JM
    Arch Dis Child; 2002 Aug; 87(2):139-44. PubMed ID: 12138066
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Growth of patients with 21-hydroxylase deficiency: an analysis of the factors influencing adult height.
    Jääskeläinen J; Voutilainen R
    Pediatr Res; 1997 Jan; 41(1):30-3. PubMed ID: 8979286
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Longer term outcome in females with congenital adrenal hyperplasia (CAH): the Cardiff experience.
    Premawardhana LD; Hughes IA; Read GF; Scanlon MF
    Clin Endocrinol (Oxf); 1997 Mar; 46(3):327-32. PubMed ID: 9156043
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.